See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Dr. Reddy's Laboratories Ltd (RDY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dr. Reddy's Laboratories Ltd (RDY) - free report >>
Image: Bigstock
New Strong Sell Stocks for May 22nd
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
The Stars Group Inc. is the owner and operator of gaming and related interactive entertainment businesses. The Zacks Consensus Estimate for its current year earnings has been revised 6.4% downward over the last 30 days.
Berkshire Hills Bancorp, Inc. (BHLB - Free Report) is a provider of banking products and services. The Zacks Consensus Estimate for its current year earnings has been revised 4.5% downward over the last 30 days.
Cabot Corporation (CBT - Free Report) is a provider of specialty chemicals and performance materials. The Zacks Consensus Estimate for its current year earnings has been revised 5.9% downward over the last 30 days.
CenterState Bank Corporation is the owner and operator of a holding company for CenterState Bank. The Zacks Consensus Estimate for its current year earnings has been revised 7.1% downward over the last 30 days.
Dr. Reddy's Laboratories Limited (RDY - Free Report) is the owner and operator of an integrated pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 30.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.